Stronger Sell Today ADMA ranks #4115 as SELL CANDIDATE. Weaker Sell
Today ADMA ranks #4115 as SELL CANDIDATE.

ADMA stock ADMA Biologics Inc

ADMA stock
ADMA Biologics Inc

23 January 2019
Change -5.29%
Chart period: 2018-10-24 - 2019-01-23




Request Prediction

ADMA Biologics Inc Stock Analysis

Technical stock analysis for 23 January 2019

Sell candidate since 2019-01-10 Loss -5.01%
Shorts n/a
Cash n/a
Loans n/a
Beta 3.03
ROA -67.75

ADMA Biologics Inc fell by -5.29% in the last day from $3.40 to $3.22 The price has fallen in 6 of the last 10 days and is down by -5.57% for this period. Volume has increased in the last day by 56 379 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 284 175 shares bought and sold for approximately $915 044.00.

Close price at the end of the last trading day (Wednesday, 23rd Jan 2019) of the ADMA stock was $3.22. This is 5.29% less than the trading day before Tuesday, 22nd Jan 2019.

During day the stock fluctuated 9.18% from a day low at $3.16 to a day high of $3.45.

30 day high of the ADMA stock price was $3.64 and low was $2.08.
90 day high was $5.93 and low was $2.08.
52 week high for the ADMA Biologics Inc - $6.96 and low - $2.08.


ADMA Biologics Inc lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $3.53 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -47.74% during the next 3 months and, with 90% probability hold a price between $0.63 and $1.84 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. ADMA Biologics Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $3.33 and $3.59. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday January 09, 2019, which indicates further falls until a new bottom pivot has been found. ADMA Biologics Inc gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 71 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

ADMA Biologics Inc finds support from accumulated volume at $3.14.

Support: $3.14 Price: $3.22 Resistance: $3.36


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.29 between high and low, or 9.18%. For the last week, the stock has had a daily average volatility of 8.16%.

The stock is overbought on RSI14 and the RSI has been falling for the last couple of days. This together with the fact that the stock is in the upper part of the trend poses a possible good selling opportunity for the short-term trader. However, one should note that some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


ADMA Biologics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today ADMA ranks #4115 as SELL CANDIDATE. Weaker Sell
Today ADMA ranks #4115 as SELL CANDIDATE.